Wolverine Trading, LLC Astrazeneca PLC Transaction History

Wolverine Trading, LLC

$133 Billion
Q3 2025

A detailed history of Wolverine Trading, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Wolverine Trading, LLC holds 17,192 shares of AZN stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,192

Holding current value

$1.54 Million

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$68.72 - $82.11 $1.18 Million - $1.41 Million	17,192 New	17,192 $1.32 Million
Q1 2025 May 15, 2025	BUY	$65.37 - $77.96 $4.07 Million - $4.85 Million	62,192 Added 519.05%	74,174 $5.45 Million
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $396,706 - $499,523	6,277 Added 110.03%	11,982 $785,000
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $199,955 - $228,512	2,608 Added 84.21%	5,705 $444,000
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $1.31 Million - $1.58 Million	-19,586 Reduced 86.35%	3,097 $241,000

Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $752,988 - $858,354	12,338 Added 119.27%	22,683 $1.54 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $2.61 Million - $2.93 Million	-42,230 Reduced 80.32%	10,345 $696,000
Q3 2023 Nov 15, 2023	BUY	$64.85 - $71.7 $3.41 Million - $3.77 Million	52,575 New	52,575 $3.56 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $654,612 - $742,205	10,366 Added 35.67%	39,429 $2.73 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $740,671 - $962,421	13,663 Added 88.72%	29,063 $1.97 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $548,810 - $1.41 Million	10,351 Added 205.01%	15,400 $846,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $508,687 - $610,665	-8,584 Reduced 62.96%	5,049 $338,000
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $759,630 - $915,046	13,633 New	13,633 $915,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $1.56 Million - $1.85 Million	-28,954 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $1.61 Million - $1.76 Million	28,954 New	28,954 $1.73 Million
Q2 2021 Aug 06, 2021	SELL	$48.42 - $60.18 $1.14 Million - $1.41 Million	-23,504 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $1.26 Million - $1.45 Million	-26,723 Reduced 53.2%	23,504 $1.17 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $310,964 - $371,850	-6,409 Reduced 11.32%	50,227 $2.52 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $1.21 Million - $1.39 Million	22,714 Added 66.96%	56,636 $3.12 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $332,301 - $426,440	-7,710 Reduced 18.52%	33,922 $1.8 Million
Q1 2020 May 11, 2020	BUY	$37.79 - $51.33 $796,991 - $1.08 Million	21,090 Added 102.67%	41,632 $1.85 Million
Q4 2019 Feb 12, 2020	BUY	$42.46 - $50.46 $872,213 - $1.04 Million	20,542 New	20,542 $1.03 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $337,474 - $409,077	-9,509 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $149,725 - $168,532	4,062 Added 74.57%	9,509 $359,000
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $536,451 - $612,998	-15,433 Reduced 73.91%	5,447 $216,000
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $688,413 - $764,834	20,880 New	20,880 $730,000

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Astrazeneca PLC Transaction History